Search

Your search keyword '"Stefan Aschauer"' showing total 116 results

Search Constraints

Start Over You searched for: Author "Stefan Aschauer" Remove constraint Author: "Stefan Aschauer" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
116 results on '"Stefan Aschauer"'

Search Results

1. A 64k pixel CMOS-DEPFET module for the soft X-rays DSSC imager operating at MHz-frame rates

2. Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. persistent atrial fibrillation

3. Cardiac remodeling in ambitious endurance-trained amateur athletes older than 50 years-an observational study.

4. Endurance Training Improves Oxygen Uptake and Endurance Capacity in Patients With Moderate to Severe Valvular Disease

5. Impact of Systemic Volume Status on Cardiac Magnetic Resonance T1 Mapping

6. Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis

7. Riociguat for the treatment of transthyretin cardiac amyloidosis: data from a named patient use program in Austria

8. Presence of ´isolated´ tricuspid regurgitation should prompt the suspicion of heart failure with preserved ejection fraction.

9. Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular Performance.

10. The DEPFET Sensor-Amplifier Structure: A Method to Beat 1/f Noise and Reach Sub-Electron Noise in Pixel Detectors

12. Bioimpedance Spectroscopy Reveals Important Association of Fluid Status and T 1 ‐Mapping by Cardiovascular Magnetic Resonance

13. Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement

14. Feature Tracking of Global Longitudinal Strain by Using Cardiovascular MRI Improves Risk Stratification in Heart Failure with Preserved Ejection Fraction

15. Impact of treatment strategies on long-term outcome of CTO patients

16. Light‐chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome

17. Determinants of Bioprosthetic Aortic Valve Degeneration

19. Transcatheter Versus Surgical Valve Repair in Patients with Severe Mitral Regurgitation

20. Volume Status Impacts CMR–Extracellular Volume Measurements and Outcome in AS Undergoing TAVR

21. Prognostic impact of left atrial function in heart failure with preserved ejection fraction in sinus rhythm vs. atrial fibrillation

22. Diagnostic assessment and procedural imaging for transcatheter edge-to-edge tricuspid valve repair: a step-by-step guide

23. Native T1 time of right ventricular insertion points by cardiac magnetic resonance: relation with invasive haemodynamics and outcome in heart failure with preserved ejection fraction

24. Angs (Angiotensins) of the Alternative Renin-Angiotensin System Predict Outcome in Patients With Heart Failure and Preserved Ejection Fraction

25. Diagnostic and Prognostic Utility of Cardiac Magnetic Resonance Imaging in Aortic Regurgitation

26. Visual assessment of right ventricular function by echocardiography: how good are we?

27. Syncope

28. Super-resolution for x-ray applications with pixelated semiconductor tracking detectors using convolutional neural networks

29. Sex Differences in Left Ventricular Remodeling and Outcomes in Chronic Aortic Regurgitation

30. Right ventricular rather than left ventricular systolic dysfunction predicts outcome in patients undergoing transcatheter aortic valve implantation: insights from cardiac magnetic resonance imaging

31. Cardiac remodeling in ambitious endurance-trained amateur athletes older than 50 years

32. Assessment of the Non-Linear Response of DEPFET Sensors with Signal Compression

33. Right ventricular function and outcome in patients undergoing transcatheter aortic valve replacement

34. Mechanisms of heart failure in transthyretin vs. light chain amyloidosis

35. Identification of Subclinical Microvascular Biomarkers in Coronary Heart Disease in Retinal Imaging

36. Diameter of the Pulmonary Artery in Relation to the Ascending Aorta: Association with Cardiovascular Outcome

37. Molecular effects of the soluble guanylyl cyclase stimulator Riociguat in experimental cirrhosis and impact on transaminases in patients

38. Fluid status and outcome in patients with heart failure and preserved ejection fraction

39. Impact of Left Atrial Phasic Function in Heart Failure With Preserved Ejection Fraction

41. Cardiac Magnetic Resonance T1 Mapping in Cardiac Amyloidosis

42. Serum levels of gamma-glutamyltransferase predict outcome in heart failure with preserved ejection fraction

43. P2730Pericardial and pleural effusion in patients with cardiac amyloidosis

44. P2727Hemodynamic profiles in patients with cardiac amyloidosis

45. P896Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy

46. 131Left atrial phasic function in heart failure with preserved ejection fraction: cardiac magnetic resonance myocardial feature tracking, invasive hemodynamics and outcome

47. P5258Native T1 time of right ventricular insertion points by CMR: relation with invasive hemodynamics and outcome in HFPEF

48. P895Apical sparing in patients without cardiac amyloidosis

49. P2726Extremely boosted prediction of cardiac amyloidosis by routine laboratory paramaters

50. P4128The right heart in patients undergoing transcatheter aortic valve replacement: insights from cardiac magnetic resonance imaging

Catalog

Books, media, physical & digital resources